aristolochic acid i has been researched along with Communicable Diseases in 2 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MOESE, JR | 1 |
| MOSER, H | 1 |
2 other studies available for aristolochic acid i and Communicable Diseases
| Article | Year |
|---|---|
[ALTERATION OF INFECTION RESISTANCE BY ARISTOLOCHIC ACID].
Topics: Animals; Aristolochic Acids; Communicable Diseases; Drug Resistance; Drug Resistance, Microbial; Inf | 1963 |
[CLINICAL EXPERIENCE WITH ARISTOLOCHIC ACID IN EARLIER THERAPY-RESISTANT PROLONGED SUPPURATIONS].
Topics: Aristolochic Acids; Communicable Diseases; Drug Resistance; Drug Resistance, Microbial; Humans; Phen | 1963 |